The
The Max-Planck-Institut für Psychiatrie is a renowned research institution of the Max-Planck-Gesellschaft, specializing in the study of psychiatric disorders and their neurobiological foundations. The research encompasses a wide range of topics, including the investigation of genetic, neurobiological, and environmental factors that contribute to the development of psychiatric disorders.
The main mission of the institute is to improve the quality of life for people with psychiatric disorders through innovative research and clinical practice. The values of the institute include excellence in research, interdisciplinary collaboration, and commitment to the health and well-being of patients.
Although specific sustainability goals are not explicitly mentioned, the institute places great importance on the long-term improvement of psychiatric care through continuous research and the development of new treatment methods. This indirectly contributes to social sustainability by enhancing public health.
The Max-Planck-Institut für Psychiatrie is an important part of the scientific community and plays a central role in the research and treatment of psychiatric disorders. Through its work, it contributes to the development of new therapies and the improvement of the quality of life for those affected.
